MIRA
INFORM REPORT
|
Report Date : |
23.05.2008 |
IDENTIFICATION
DETAILS
|
Name : |
MINOVA LIFE SCIENCES PRIVATE LIMITED |
|
|
|
|
Registered Office : |
New No. 128, Old No. 62, 2nd Main Road, Chamarajpet,
Bangalore – 560018, Karnataka |
|
|
|
|
Country : |
India |
|
|
|
|
Date of Incorporation : |
11.05.2007 |
|
|
|
|
Com. Reg. No.: |
042778 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24232KA2007PTC042778 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
BLRM12305G |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAFCM0769G |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer, Trader Exporter and Importer of Pharmaceuticals
Formulation. |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Status : |
New Company |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a new Company and has shown Satisfactory progress. Trade relations
are fair. Payments are reported as Slow but Correct. The Company can be considered for Small to mediocre business dealings. |
INFORMATION PARTED
BY
|
Name : |
Mr. Himat Jain |
|
Designation : |
G M Marketing |
|
Contact No.: |
91-9886061477 |
LOCATIONS
|
Registered Office : |
New No. 128, Old No. 62, 2nd Main Road, Chamarajpet,
Bangalore – 560018, Karnataka, India. |
|
Tel. No.: |
91-80-26611156 / 26743981 |
|
Mobile No.: |
91-9945806347 / 9886061477 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
2000 Sq.ft. |
|
Location : |
Rented |
|
|
|
|
Branches : |
71, Minova Chambers, 7th Cross, 1st Main,
Chamarjeet, Banglore - 560018, Karnataka, India |
DIRECTORS
|
Name : |
Mr. Arvind Jain |
|
Designation : |
Director |
|
Address : |
157, 1st Main, A R Compound, Mysore Road, Bangalore –
560018, Karnataka, India |
|
Date of Birth/Age : |
29.12.1979 |
|
Qualification : |
B. Pharma |
|
|
|
|
Name : |
Mr. Mukesh Jain |
|
Designation : |
Director |
|
Address : |
No. 4, M S Lane, K J Market, IInd Floor, Jumma Masjid Road, Bangalore
– 56002, Karnataka, India. |
|
Date of Birth/Age : |
19.05.1973 |
|
Qualification : |
Graduate |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
As on 05.05.2007
|
Names of Shareholders |
No. of Shares |
|
Mr. Mukesh Jain |
1000 |
|
Mr. Arvind Jain |
200 |
|
Ms. Seema Punamiya |
4000 |
|
Mrs. Mamta Jain |
1200 |
|
Mrs. Kusum Jain |
1200 |
|
Mrs. Chanda Jain |
1200 |
|
Mrs. Mamta Jain |
1200 |
|
Total |
10000 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer, Trader Exporter and Importer of Pharmaceuticals
Formulation. |
|
|
|
|
Products : |
v Antibiotics/Infusion (Parenteral) v Anti-Malarial/Anthelmintics v Anti-Allergic/Anti-Asthmatics v Cardiac/Diabetic v Anti-Inflammatory v Analgesic And Antispasmodic v Vitamin v Minerals v Protein And Other Nutritional Supplements v Pre And Pro Biotic And Rehydration Salts/ Antacids v Anti Flatulent v Anti Ulcer And Anti Emetics v Dental Range v Eye/Ear Drops v Nasal Drops v Ointment v Pediatrics |
|
|
|
|
Exports : |
|
|
Countries : |
Sri Lanka |
|
|
|
|
Imports : |
|
|
Products : |
v Raw Materials v Finished Goods |
|
Countries : |
v Chinese Company
(Planning to Import in future) |
|
|
|
|
Terms : |
|
|
Selling : |
Cash / Credit (30 days) |
|
|
|
|
Purchasing : |
L/C |
GENERAL
INFORMATION
|
Customers : |
Wholesalers |
|
|
|
|
No. of Employees : |
25 |
|
|
|
|
Bankers : |
ICICI Bank – Chamarajpet Branch, Bangalore Punjab national Bank - Chamarajpet Branch, Bangalore State Bank of India - Chamarajpet Branch, Bangalore |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Not Available |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10,000 |
Equity Shares |
Rs. 10/- Each |
Rs. 0.100 million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10,000 |
Equity Shares |
Rs. 10/- Each |
Rs. 0.100 million |
FINANCIAL DATA
[all figures are in Rupees Millions]
|
Particulars |
31.03.2008 |
|
Sales Turnover (Estimated) |
20.000 |
LOCAL AGENCY
FURTHER INFORMATION
Table
|
Parameters |
Details |
|
Statutory
Approvals |
|
|
Income Tax Registration (PAN) |
ABWPI3025D |
|
VAT / TIN Registration |
29640759364 |
|
Import Export Code |
0707023441 |
|
Name of Bank |
ICICI |
|
Current Account Number |
625405015494 |
|
Account Since |
1 Year |
|
|
|
|
Credibility
Factors |
|
|
India Mart Client Since |
1 Month |
|
|
|
|
Trade
Affiliations |
|
|
SSI Registration |
No |
|
Export Promotion Council |
No |
|
|
|
|
Chambers of Commerce Membership |
No |
|
Standards
and Certifications |
|
|
Quality Management Systems |
Yes |
|
Environment Management Systems |
Yes |
|
Safety Certificates |
Yes |
|
Product Certificates |
Yes |
|
Other Certificates |
ISO – 9001:2000 |
Trade References
v S V Pharma, Mysore
v Biogen Pharma, Chennai
v C D Marketing, Surat
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets theyre seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
The market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
The Governance Assessment focuses principally on the interactions
bettheyen a company’s management, its Board of Directors, Shareholders and
other financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 42.84 |
|
UK Pound |
1 |
Rs. 84.78 |
|
Euro |
1 |
Rs. 67.32 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
-- |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
-- |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
4 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
26 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of theyighted scores obtained from each of the major sections of this report.
The assessed factors and their relative theyights (as indicated through %) are
as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar theyight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, they have no basis upon which to
recommend credit dealings |
No Rating |
|